Affymetrix, Inc. (AFFX) - Medical Equipment - Deals and Alliances Profile

Date: July 20, 2016
Pages: 62
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AD12122D1CFEN
Leaflet:

Download PDF Leaflet

Affymetrix, Inc. (AFFX) - Medical Equipment - Deals and Alliances Profile
Summary

Affymetrix, Inc. (Affymetrix) provides life science, and molecular diagnostic products for analysis of biological systems at gene, protein and cellular level. It offers products for two major applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument systems, namely, GeneChip, GeneTitan and GeneAtlas that include instruments, consumables and software. Its product portfolio consists of microarray solutions, eBioscience immunology reagents, molecular biology kits and reagents, and others. The company has manufacturing facilities in San Diego, Cleveland, Vienna, and Singapore. Its products are widely used by genomic research centers; academic institutions; government and private laboratories; and pharmaceutical, diagnostic, and biotechnology companies across the US, Europe, Latin America, and Asia. Affymetrix is headquartered in Santa Clara, California, the US.

Affymetrix, Inc. (AFFX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Affymetrix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deal Details
Venture Financing
Eureka Genomics Raises US$3.7 Million In Private Financing
Partnerships
Affymetrix Enters into Licensing Agreement with Peptide Groove
Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests
Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology
Affymetrix Enters Into Licensing Agreement With Genisphere
Affymetrix Enters Into An Agreement With Signature Diagnostics
Affymetrix Enters into Agreement with Reveal Biosciences
XRGenomics Enters into Research Agreement with Affymetrix
Affymetrix Enters into Distribution Agreement with Luminex
Cytox Enters into Joint Development Partnership with Affymetrix
Affymetrix Enters Into Integration Agreement With CollabRx
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools
Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay
Affymetrix Enters Into Co-Development Agreement With Pathgen Dx
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests
Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics
Affymetrix Enters Into Distribution Agreement With Thermo Fisher
TriLink BioTechnologies Signs An Agreement With Affymetrix
Equity Offering
Affymetrix to Raise USD50 Million in Private Placement of Shares
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million
Debt Offering
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million
Acquisition
Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion
Origin Technologies Withdraws Plan to Acquire Affymetrix
Affymetrix Completes Acquisition Of eBioscience For US$315 Million
Affymetrix, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Feb 17, 2016: Affymetrix Reports Fourth Quarter 2015 Operating Results
Oct 28, 2015: Affymetrix Reports Third Quarter 2015 Operating Results
Jul 29, 2015: Affymetrix Reports Second Quarter 2015 Operating Results
Apr 29, 2015: Affymetrix Reports First Quarter 2015 Operating Results
Feb 04, 2015: Affymetrix Reports Fourth Quarter and Fiscal Year 2014 Results
Jan 12, 2015: Affymetrix Announces Preliminary Fourth Quarter 2014 Revenue of Approximately $93 Million and the Appointment of Merilee Raines to the Board of Directors
Corporate Communications
May 18, 2015: Affymetrix Appoints Riccardo Pigliucci to Board of Directors
Legal and Regulatory
Oct 13, 2015: ENZO Biochem Reaches $10 Million Patent Infringement Settlement with Affymetrix
Product News
Mar 08, 2016: Affymetrix Receives Grant for Non-Invasive Genomic Profiling of Bladder Cancer
Oct 27, 2015: Affymetrix and Athletigen Partner to Advance Genetics in Human Athletic Performance
May 07, 2015: N-of-One To Provide CNV Analysis Interpretation For Affymetrix’s OncoScan Kit
Other Significant Developments
Jan 30, 2015: Affymetrix Chairman and Founder to Retire from Board of Directors
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Affymetrix, Inc., Medical Equipment, Key Facts, 2015
Affymetrix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Affymetrix, Inc., Deals By Market, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Eureka Genomics Raises US$3.7 Million In Private Financing
Affymetrix Enters into Licensing Agreement with Peptide Groove
Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests
Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology
Affymetrix Enters Into Licensing Agreement With Genisphere
Affymetrix Enters Into An Agreement With Signature Diagnostics
Affymetrix Enters into Agreement with Reveal Biosciences
XRGenomics Enters into Research Agreement with Affymetrix
Affymetrix Enters into Distribution Agreement with Luminex
Cytox Enters into Joint Development Partnership with Affymetrix
Affymetrix Enters Into Integration Agreement With CollabRx
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools
Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay
Affymetrix Enters Into Co-Development Agreement With Pathgen Dx
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests
Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics
Affymetrix Enters Into Distribution Agreement With Thermo Fisher
TriLink BioTechnologies Signs An Agreement With Affymetrix
Affymetrix to Raise USD50 Million in Private Placement of Shares
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million
Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion
Origin Technologies Withdraws Plan to Acquire Affymetrix
Affymetrix Completes Acquisition Of eBioscience For US$315 Million
Affymetrix, Inc., Key Competitors
Affymetrix, Inc., Key Employees
Affymetrix, Inc., Other Locations
Affymetrix, Inc., Subsidiaries

LIST OF FIGURES

Affymetrix, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Affymetrix, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Affymetrix, Inc. (AFFX) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: